🔎 Trials Near Me

Home › Cancer (all types) › NCT06814977

An Acupuncture Study for Cancer Survivors With Joint Pain

RecruitingHealthy volunteers welcome

Researching the Implementation of Acupuncture for Chronic Musculoskeletal Pain in Diverse Underserved Cancer Survivors (ReIMAGINE)

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* English- or Spanish-speaking adults
* Non white or Hispanic women with a prior cancer diagnosis
* Stable oncological disease or no evidence oncological of disease per clinical documentation or clinician assessment
* Worst pain rated ≥4 on a 0-10 scale in the preceding week
* ≥15 days with pain in the past 30 days
* Pain lasting ≥1 month
* Willing and able to complete questionnaires and other study activities
* Willing and able to provide informed consent for the trial

Exclusion Criteria:

* Completed active treatment (chemotherapy, surgery, radiation, transplantation) \<4 weeks prior to study
* Maintenance therapies are allowed
* Pain attributed to inflammatory arthritis (e.g., rheumatoid arthritis, gout)
* Other non-musculoskeletal pain syndromes (eg, headache, visceral abdominal pain, neuropathic pain) can be present as comorbid conditions if the patient reports musculoskeletal pain as the primary source of pain
* Procedures involving affected joints within the last month or planned in the next 14 weeks
* Acupuncture use for pain in the past three months
* Implanted electronic device (e.g., pacemaker)

About the study

The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for cancer survivors with joint pain.

What is being tested

Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 60 · Started: Jan 31, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06814977

Locations in the U.S.

New YorkMemorial Sloan Kettering Cancer Center (All protocol activites), New York
Jamaica Hospital Medical Center, Richmond Hill

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.